Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
RAR-related orphan receptor gamma | 4 | 0 | 0 | 4 |
AR protein | 6 | 0 | 0 | 6 |
aldehyde dehydrogenase 1 family, member A1 | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
retinoic acid nuclear receptor alpha variant 1 | 5 | 0 | 0 | 5 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 4 | 0 | 0 | 4 |
Cellular tumor antigen p53 | 5 | 0 | 0 | 5 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 3 | 0 | 0 | 3 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 1 | 0 | 0 | 1 |
Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
Chain A, HADH2 protein | 2 | 0 | 0 | 2 |
Chain B, HADH2 protein | 2 | 0 | 0 | 2 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Chain A, 2-oxoglutarate Oxygenase | 2 | 0 | 0 | 2 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
Luciferase | 2 | 0 | 0 | 2 |
thioredoxin reductase | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
Mcl-1 | 0 | 1 | 0 | 1 |
phosphopantetheinyl transferase | 1 | 0 | 0 | 1 |
MPI protein | 0 | 1 | 0 | 1 |
USP1 protein, partial | 1 | 0 | 0 | 1 |
Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
PPM1D protein | 3 | 0 | 0 | 3 |
TDP1 protein | 5 | 0 | 0 | 5 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
alkaline phosphatase, intestinal | 0 | 0 | 1 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
regulator of G-protein signaling 4 | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
G | 3 | 0 | 0 | 3 |
67.9K protein | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
pyruvate kinase | 1 | 0 | 0 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
CDK5 | 0 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 2 | 0 | 0 | 2 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 0 | 1 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 0 | 1 | 1 |
chromobox protein homolog 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 4 | 0 | 0 | 4 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
geminin | 5 | 0 | 0 | 5 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
Vif | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
survival motor neuron protein isoform d | 1 | 0 | 0 | 1 |
cytochrome P450 3A4 isoform 1 | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 0 | 1 | 0 | 1 |
alkaline phosphatase, germ cell type preproprotein | 0 | 0 | 1 | 1 |
endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 2 | 0 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 1 | 0 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Interferon beta | 5 | 0 | 0 | 5 |
HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
Integrin beta-3 | 1 | 0 | 0 | 1 |
Integrin alpha-IIb | 1 | 0 | 0 | 1 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 2 | 0 | 0 | 2 |
Endothelin receptor type B | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 2 | 0 | 0 | 2 |
Endothelin-1 receptor | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 2 | 0 | 0 | 2 |
Histamine H2 receptor | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 2 | 0 | 0 | 2 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
GABA theta subunit | 2 | 0 | 0 | 2 |
Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit epsilon | 2 | 0 | 0 | 2 |
cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
large T antigen | 0 | 1 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
glp-1 receptor, partial | 1 | 0 | 0 | 1 |
SMAD family member 2 | 2 | 0 | 0 | 2 |
SMAD family member 3 | 2 | 0 | 0 | 2 |
GLI family zinc finger 3 | 6 | 0 | 0 | 6 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
progesterone receptor | 5 | 0 | 0 | 5 |
glucocorticoid receptor [Homo sapiens] | 5 | 0 | 0 | 5 |
retinoid X nuclear receptor alpha | 3 | 0 | 0 | 3 |
estrogen-related nuclear receptor alpha | 5 | 0 | 0 | 5 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
pregnane X nuclear receptor | 6 | 0 | 0 | 6 |
estrogen nuclear receptor alpha | 6 | 0 | 0 | 6 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
IDH1 | 3 | 0 | 0 | 3 |
aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 4 | 0 | 0 | 4 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 2 | 0 | 0 | 2 |
thyroid hormone receptor beta isoform 2 | 3 | 0 | 0 | 3 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 3 | 0 | 0 | 3 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 1 | 2 |
Cytochrome P450 3A4 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 0 | 0 | 1 |
Mast/stem cell growth factor receptor Kit | 0 | 1 | 1 | 2 |
Breakpoint cluster region protein | 0 | 0 | 1 | 1 |
Platelet-derived growth factor receptor alpha | 0 | 1 | 1 | 2 |
Glutamate receptor 2 | 3 | 0 | 0 | 3 |
Cytochrome P450 3A5 | 0 | 0 | 0 | 1 |
Spike glycoprotein | 2 | 0 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 3 | 0 | 0 | 3 |
Ataxin-2 | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
plasminogen precursor | 1 | 0 | 0 | 1 |
urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 2 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 4 | 0 | 4 |
Multidrug resistance-associated protein 4 | 0 | 4 | 0 | 4 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Histamine H2 receptor | 0 | 4 | 0 | 4 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Adenosine receptor A2a | 0 | 2 | 0 | 2 |
7,8-dihydro-8-oxoguanine triphosphatase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 4 | 0 | 4 |
Toll-like receptor 8 | 0 | 0 | 1 | 1 |
Toll-like receptor 7 | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 2 | 0 | 0 | 2 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
pregnane X receptor | 1 | 0 | 0 | 1 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
PINK1 | 1 | 0 | 0 | 1 |
nonstructural protein 1 | 2 | 0 | 0 | 2 |
Parkin | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 2 | 0 | 0 | 2 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 1 | 0 | 0 | 1 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 2 | 0 | 0 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 3 | 0 | 0 | 3 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 3 | 1 | 4 |
Glucocorticoid receptor | 0 | 6 | 2 | 13 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Progesterone receptor | 0 | 4 | 1 | 6 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Mineralocorticoid receptor | 0 | 3 | 1 | 4 |
Androgen receptor | 0 | 4 | 2 | 6 |
Androgen receptor | 0 | 5 | 0 | 5 |
Androgen receptor | 0 | 0 | 1 | 1 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 3 | 1 | 4 |
hypoxia-inducible factor 1 alpha subunit | 2 | 0 | 0 | 2 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Histamine H1 receptor | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
thyroid hormone receptor beta isoform a | 1 | 0 | 0 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Protease | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |